A Phase I, 2-part (Part 1 Being a Single Dose Escalation and Part 2, a Parallel Group) Study of Toll-like Receptor (TLR4) Agonist (GSK1795091) in Healthy Subjects
Clinical trial NCT02798978 · COMPLETED
Trial details
- NCT number
- NCT02798978
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-10
- Primary completion
- 2017-10-13
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.